Stock ABTI ALTEROLA BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Alterola Biotech, Inc.

Equities

ABTI

US02152V1035

Market Closed - OTC Markets
Other stock markets
 09:30:00 2024-04-22 am EDT 		5-day change 1st Jan Change
0.0037 USD -31.48% Intraday chart for Alterola Biotech, Inc. -.--% +2.78%
Feb. 20 Alterola Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 Alterola Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alterola Biotech, Inc. Announces Executive Changes
CI
Alterola Biotech, Inc. Executive Changes
CI
Alterola Biotech, Inc. Appoints Terry Rafih as A Member of Board of Directors
CI
Alterola Biotech, Inc. Announces Removal of Lalit Kumar Verma as A Director
CI
Alterola Biotech : Board Replaces Outgoing CFO Larson Elsmore With Timothy Rogers as Interim CFO
MT
Alterola Biotech, Inc. Announces Executive Changes
CI
Alterola Biotech, Inc. Confirms Appointment of Hunter Land to the Board
CI
Alterola Biotech, Inc. Announces Management Changes
CI
Alterola Biotech, Inc. Accepts Resignation of Peter Maddocks as CFO
CI
Alterola Biotech, Inc. Announces Executive Changes
CI
Alterola Biotech, Inc. Announces Board Changes
CI
Alterola Biotech, Inc. Announces Management Changes
CI
Alterola Biotech, Inc. Announces Changes in CEO
CI
Alterola Biotech, Inc. Announces Management Changes
CI
Alterola Biotech Inc. Announces Executive Changes
CI
Alterola Biotech, Inc. Announces Executive Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABTI Stock
  4. News Alterola Biotech, Inc.
  5. Insiders